ArticleThrombosis journal2018

Recombinant human soluble thrombomodulin improves mortality in patients with sepsis especially for severe coagulopathy: a retrospective study.

Takahiro Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.